Metabolic dysfunction-associated fatty liver disease (MAFLD)

also known as non-alcoholic fatty liver disease (NAFLD)，is the most common noninfectious chronic liver disease at present. It will progress to liver cirrhosis and even hepatocellular carcinoma without effective treatment. Making diagnosis of MAFLD at the early stage is important for optimizing treatment plan and prevent progression. Liver biopsy is considered as the gold standard for the diagnosis and grading of MAFLD. However

it can be invasive and may cause bleeding during the procedure. Thus

it is necessary to find out more convenient and noninvasive methods to establish MAFLD severity. Here we reviewed and summarized the latest imaging techniques in the diagnosis of MAFLD.